Chemical probe to dissect role of potential cancer-causing proteins

October 26, 2015, Institute of Cancer Research
Electron microscopic image of a single human lymphocyte. Credit: Dr. Triche National Cancer Institute

Scientists have created a highly specific and well-characterised chemical probe which can switch off two important proteins implicated in cancer—shedding new light on the role these proteins play in driving cancer cell proliferation.

A major new study, published in Nature Chemical Biology today (Monday), announces the discovery of the first highly selective modulator of two proteins called CDK8 and CDK19—members of an important family known as kinases—whose function is to regulate gene activation.

This well-characterised will allow more precise analysis than ever before of the biological the roles of CDK8 and CDK19 in and other cells.

The study comes from a research partnership between The Institute of Cancer Research, London, the University of Cardiff, pharmaceutical company Merck Serono, and Cancer Research Technology—the commercial arm of Cancer Research UK, which was one of the study's funders.

The chemical probe (CCT251545) - published by the same team earlier this year—was discovered by screening a large collection of chemicals against the WNT signalling pathway in cancer cells.

In the new study, the team describe the discovery that CDK8 and CDK19 are the biochemical targets of CCT251545.

The researchers report their work using a range of biological and biophysical techniques to show that CCT251545 potently and selectively binds to CDK8 and CDK19. They go on to explain how the probe binds to CDK8 and CDK19 and how this in turn blocks the WNT signalling pathway, a known driver of many bowel cancers.

Study co-leader Professor Julian Blagg, Deputy Director of the Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London, said:

"This collaborative study describes our detailed characterisation of CCT251545 as a highly specific chemical probe for the kinases CDK8 and CDK19 that control gene activation. Publishing our work will enable the scientific community to use our probes to further explore the role of these closely related proteins in cancer and other diseases."

Study co-leader Professor Trevor Dale, Deputy Head of Molecular Biosciences at Cardiff University, said:

"This study is a superb example of how an inter-disciplinary team of scientists from academia and industry can cooperate to produce work of the highest quality. It is great to look back and see how much was achieved."

Fellow study author Professor Paul Workman, Chief Executive of The Institute of Cancer Research, London, said:

"The discovery of this new, highly specific chemical probe could help us to shed new light on an important pathway in cancer—and in biology generally—and help researchers to understand how to influence and exploit it.

"Chemical probes are very important tools in the development of new drugs, because they allow us to explore the effect of blocking cancer-causing proteins in cells. Our discovery through collaborative team science of highly potent, selective inhibitors for cancer proteins addresses an important need to find such probes for the huge area of the cancer signalling network that is still largely unexplored."

Explore further: Study shows molecule isolated from sea sponges may be effective treatment against leukemia

More information: A selective chemical probe for exploring the role of CDK8 and CDK19 in human disease, Nature Chemical Biology, DOI: 10.1038/nchembio.1952

Related Stories

Study shows molecule isolated from sea sponges may be effective treatment against leukemia

September 28, 2015
A team of Harvard researchers and other collaborators led by Professor of Chemistry and Chemical Biology Matthew Shair has demonstrated that a molecule isolated from sea sponges and later synthesized in Shair's lab, can halt ...

A new approach to improving cancer chemotherapy

August 7, 2012
(Medical Xpress) -- Chemotherapy kills tumor cells, but it also wreaks havoc on the rest of the body. A team of researchers led by Igor Roninson of the South Carolina College of Pharmacy just reported the discovery of a new ...

Clearing a path for cancer research

September 10, 2015
EMBL-EBI researchers have developed a new computational method to study biological signalling networks in healthy and cancer cells.

Protein linked with tumor growth could be potential target for cancer-fighting drugs

June 6, 2013
As tumors grow, their centers are squeezed of oxygen. And so tumors must flip specific genetic switches to survive in these hypoxic environments. A series of studies funded to do only basic science and published today in ...

Recommended for you

Fully reprogrammed virus offers new hope as cancer treatment

May 25, 2018
A cancer treatment that can completely destroy cancer cells without affecting healthy cells could soon be a possibility, thanks to research led by Cardiff University.

Research could help fine-tune cancer treatment

May 25, 2018
Cancer therapies that cut off blood supply to a tumour could be more effective in combination with existing chemotherapeutic drugs—according to new research from the University of East Anglia.

Increasing physical activity linked to better immunity in breast cancer patients, study finds

May 25, 2018
A new study from the University of Toronto's Faculty of Kinesiology & Physical Education has found that moderate to vigorous physical activity may help regulate the levels of C-reactive protein – an important biomarker ...

Low-fat diet tied to better breast cancer survival

May 24, 2018
(HealthDay)—Breast cancer patients who adopted a low-fat diet were more likely to survive for at least a decade after diagnosis, compared to patients who ate fattier fare, new research shows.

A cascade of immune processes offers insights to triple-negative breast cancer

May 24, 2018
Cancer is crafty. To survive and thrive, tumors find a way of thwarting our body's natural systems.

By forming clots in tumors, immune cell aids lung cancer's spread

May 24, 2018
University of North Carolina Lineberger Comprehensive Cancer Center researchers have found that by helping to form clots within tumors, immune cells that flock to a particular type of lung cancer are actually building a foundation ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.